Defence Therapeutics (TSE:DTC) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Defence Therapeutics Inc. announces the addition of molecular and antibody research expert Dr. Elias Theodorou to its board of directors, enhancing its scientific expertise. Dr. Theodorou, with over 25 years of experience, will provide guidance for Defence’s development, particularly in the USA. Additionally, the company appointed Mr. Arnab De as CFO and Corporate Secretary.
For further insights into TSE:DTC stock, check out TipRanks’ Stock Analysis page.